Krewel Meuselbach GmbH

Krewel Meuselbach, a German manufacturer of herbal and chemical-based medicines, may localize its production facilities in the Voronezh Region, the press service of the regional government reports following the meeting of the acting Governor Alexander Gusev with the Managing Director of the company Thomas Kwadt. To maintain a good position in the market, the company is considering two options for further development in Russia: contractual relations with partners or the construction of its own production facilities. There are about 220 employees in the company, the annual turnover is 50 million euro. Products are sold primarily in Germany, and represented in more than 40 countries. Russia and the CIS countries are the largest partners. The most famous products of the company are Valocordin, Gedelix, Regulax.

06 September 2018

Investor profile

Krewel Meuselbach GmbH


Company's website: https://

T: +49 2243 87-0

Private company


Krewel Meuselbach GmbH is a German pharmaceutical company established as a result of a merger of Krewel-Werke GmbH and Meuselbach Pharma GmbH. As at the time of the merger, both companies were the oldest in Germany (founded in 1893 and 1745, respectively). The company specializes in the production of herbal and chemical-based medicines. In total, it produces over a hundred of medicines, including painkillers, sedative and sleeping aids, cardiovascular disorder aids, medicines for respiratory diseases, gastroenteric aids, antiseptics.